Paul Tudor Jones Biomea Fusion, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 17,366 shares of BMEA stock, worth $78,147. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,366Holding current value
$78,147% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
121Shares Held
25.7MCall Options Held
2.56MPut Options Held
879K-
State Street Corp Boston, MA4.49MShares$20.2 Million0.0% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$16.1 Million3.07% of portfolio
-
Laurion Capital Management LP New York, NY2.72MShares$12.2 Million0.36% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$9.49 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$8.88 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $132M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...